Your browser doesn't support javascript.
loading
MAP3K11 is a tumor suppressor targeted by the oncomiR miR-125b in early B cells.
Knackmuss, U; Lindner, S E; Aneichyk, T; Kotkamp, B; Knust, Z; Villunger, A; Herzog, S.
Affiliation
  • Knackmuss U; Centre for Biological Signalling Studies (bioss), Albert-Ludwigs-University Freiburg, Freiburg, Germany.
  • Lindner SE; Division of Developmental Immunology, Biocenter Innsbruck, Medical University of Innsbruck, Innsbruck, Austria.
  • Aneichyk T; Division of Molecular Pathophysiology, Biocenter Innsbruck, Medical University of Innsbruck, Innsbruck, Austria.
  • Kotkamp B; Centre for Biological Signalling Studies (bioss), Albert-Ludwigs-University Freiburg, Freiburg, Germany.
  • Knust Z; Centre for Biological Signalling Studies (bioss), Albert-Ludwigs-University Freiburg, Freiburg, Germany.
  • Villunger A; Division of Developmental Immunology, Biocenter Innsbruck, Medical University of Innsbruck, Innsbruck, Austria.
  • Herzog S; Centre for Biological Signalling Studies (bioss), Albert-Ludwigs-University Freiburg, Freiburg, Germany.
Cell Death Differ ; 23(2): 242-52, 2016 Feb.
Article in En | MEDLINE | ID: mdl-26138442
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: MAP Kinase Kinase Kinases / MicroRNAs / Precursor Cells, B-Lymphoid Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Cell Death Differ Year: 2016 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: MAP Kinase Kinase Kinases / MicroRNAs / Precursor Cells, B-Lymphoid Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Cell Death Differ Year: 2016 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido